New Report Reveals Rare Disease Market Worth US$ 547.5 billion, With CAGR of 13.1% - With Innovative treatments and therapies

PR Newswire · 05/11/2023 06:08

COVINA, Calif., May 11, 2023 /PRNewswire/ -- According to Prophecy Market Insights "Rare Disease Market accounted for US$ 161.4 billion in 2020 and is estimated to be US$ 547.5 billion by 2030 and is anticipated to register a CAGR 13.1%"


What is Rare Disease Market?

Rare Disease is a health condition which affects smaller number of people in general population and thus, caused by person's genes and chromosomal changes. Haemophilia, cystic fibrosis, spina bifida and muscular dystrophy are some examples of Rare Disease market.

Growing implementation of technology and new drug launch has provided lucrative opportunities in target market growth. Presence of major key players & strong product pipeline, robust and favorable infrastructure and growing burden of diseases is expected to fruitful the demand for Rare Disease Market growth in coming years.

What are the Recent Key Highlights of Rare Disease Market?

  • In February 2023, CDER set to continue advance rare disease drug development including ARC (Accelerating Rare Disease Cures) program also working with National Organization for Rare Disorders in developing advanced drug development education series for patients.
  • In February 2023, Sanofi Specialty Care set to bring new therapies of Pompe, ASMD (Acid Sphingomyelinase deficiency) rare disease in India. The company has also received recommendation from Subject Expert Committee in importing & marketing two new products such as, Xenpozyme (Olipudase alfa powder) and Nexviazyme (Avalglucosidase alfa powder) for rare disease treatment.

Download a Sample Copy of Report:

Who are the Top Key players operating in the Rare Disease Market?

  • Pfizer
  • Hoffmen La Roche
  • Abbott
  • Sanofi
  • Eli lilly
  • Genelux
  • Mercks & co.
  • Glaxosmith Kline
  • Astra Zeneca
  • Eisai
  • Rexahn
  • Taino

Report Scope:



Base year for estimation


Forecast period

2023 – 2032

Market representation

Revenue in USD Million & CAGR from 2022 – 2032

Accounted in 2020

US$ 161.4 billion

Estimated to be in 2030

US$ 547.5 billion


13.1 %

Market Segmentation

·  By Drug type- Biologics and Non-Biologics

·  By Route of Administration- Oral and Injectable

·  By Phase- Preclinical, Phase1, Phase2, Phase3, Phase4

·  By Therapeutic Area- Infectious disease, Neurological, Alimentary/Metabolic, Cancer, Blood & Clotting and Others

·  By Patients- Neonatal, Pediatric, Adults

·  By Distribution Channel- Hospital & Retail Pharmacies, and E-commerce/Online Pharmacies

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Customization Scope

Avail of customized purchase options to meet your exact research needs.


What is Prophecy's Analyst View on Rare disease Market?

Development of novel drugs has contributed in target market growth. Growing research and development activities has further, facilitated the demand for Rare Disease market growth. Favorable government policies and growing strategic partnerships and acquisitions is expected to fuel the demand for Rare Disease market growth in future.

What are the latest developments for Rare Disease Market?

  • Increased focus on gene therapy
  • Growth of precision medicine
  • Use of digital technologies
  • Collaboration between stakeholders
  • Advances in rare disease research.

These developments are helping to improve diagnosis, treatment, and patient outcomes, and are transforming the Rare Disease Market. Gene therapy is a promising approach to treating rare diseases, while precision medicine is being increasingly adopted to improve treatment effectiveness and reduce side effects. Digital technologies such as telemedicine and remote monitoring are being used to improve access to care, and collaboration between stakeholders is helping to accelerate the development and approval of rare disease therapies. Finally, advances in rare disease research are helping to improve our understanding of these conditions and identify new therapeutic targets.

What are the Growth Factors of Rare disease Market?

  • Increasing prevalence of rare diseases: The prevalence of rare diseases is increasing globally, driven in part by improved diagnostics and increased awareness. This is creating a growing market for rare disease treatments.
  • Advances in medical technology: Advances in medical technology are making it possible to develop more effective and targeted therapies for rare diseases. For example, gene therapy and precision medicine are enabling highly targeted treatments for specific genetic mutations.
  • Regulatory incentives: Governments are offering incentives such as tax credits and fast-track approvals to encourage the development of rare disease therapies. This is attracting investment and speeding up the development of new treatments.
  • Patient advocacy and awareness: Patient advocacy groups are playing an increasingly important role in raising awareness of rare diseases and advocating for improved access to treatment. This is creating a more supportive environment for rare disease research and development.
  • Collaborative research efforts: Collaborative research efforts between pharmaceutical companies, academic institutions, and government agencies are helping to accelerate the development of rare disease treatments. This is leading to more rapid progress and greater innovation in the field.
  • Increasing funding for rare disease research: Governments, philanthropic organizations, and private investors are increasing their funding for rare disease research, creating a more supportive environment for innovation and development in the field.

What are the Drivers of the Rare Disease Market?

  • Unmet medical need
  • Orphan drug incentives
  • Increasing prevalence of rare diseases
  • Advancements in medical technology
  • Patient advocacy and awareness
  • Collaborative research efforts
  • Increasing funding for rare disease research

These drivers are spurring investment and innovation in the Rare Disease Market, creating opportunities for pharmaceutical companies and other stakeholders to develop and commercialize innovative therapies for rare diseases.

What are the Restrains of the Rare Disease Market?

  • High development costs
  • Regulatory challenges
  • Reimbursement challenges
  • Limited patient population
  • Lack of awareness and education among healthcare providers
  • Difficulty in diagnosis
  • Limited access to treatment in certain regions

These restraints can make it difficult for pharmaceutical companies and other stakeholders to develop and commercialize rare disease therapies, and can also make it challenging for patients to access these treatments. However, despite these restraints, there is growing momentum in the Rare Disease Market, driven by a range of growth factors such as unmet medical need, increasing prevalence of rare diseases, and advancements in medical technology.

Download PDF Brochure:

Key Reasons to Purchase the Report:

  • Market insights
  • Competitive analysis
  • Patient insights
  • Regulatory insights
  • Industry partnerships

Purchasing Rare Disease Market research reports can provide valuable insights and intelligence that help pharmaceutical companies and stakeholders to make informed decisions, understand patient needs, navigate regulatory challenges, identify partners, and gain a competitive edge in the market.

Key questions answered in this report:

  1. What is the current size of the Rare Disease Market, and what is its expected growth rate over the next few years?
  2. What are the key drivers and restraints affecting the Rare Disease Market, and how are they likely to impact market growth?
  3. Which rare diseases are most prevalent, and what are the current treatment options for these diseases?
  4. What are the emerging trends in Rare Disease Market, and what impact are they likely to have on the market in the future?
  5. What are the regulatory challenges associated with developing and commercializing rare disease therapies, and how can these challenges be addressed?
  6. Who are the key players in the Rare Disease Market, and what are their strategies for growth and market entry?

Browse Other Related Research Reports from Prophecy Market Insights:

Orphan Drugs Market is estimated to be US$ 869.6 million by 2030 and is anticipated to register a CAGR of CAGR of 10.4%

Rare Disease Diagnostics Market is estimated to be US$ 72.7 billion by 2032 and is anticipated to register a CAGR of CAGR of 8.2%

Precision Medicine Market accounted for US$ 65.66 billion in 2022 and is estimated to be US$ 168.8 billion by 2032 and is anticipated to register a CAGR of 12.9%.

About Us:                                                                      

Prophecy Market Insights is a leading provider of market research services, offering insightful and actionable reports to clients across various industries. With a team of experienced analysts and researchers, Prophecy Market Insights provides accurate and reliable market intelligence, helping businesses make informed decisions and stay ahead of the competition. The company's research reports cover a wide range of topics, including industry trends, market size, growth opportunities, competitive landscape, and more. Prophecy Market Insights is committed to delivering high-quality research services that help clients achieve their strategic goals and objectives.

To know more        

Contact Us:


Prophecy Market Insights

📞 US toll free: +1 860 531 2574

📞 Rest of world: + 91 7775049802


🌐 Website-

Follow us on:

LinkedIn | Twitter | Facebook |Youtube 



Cision View original content:

SOURCE Prophecy Market Insights